Boehringer's Pink Pill: It Ain't Viagra
The U.S. Food and Drug Administration is set to review Boehringer Ingelheim's pink pill, flibanserin, which aims to boost women's sex drive. But the drug, which didn't significantly increase sexual desire in trials, may have trouble scoring approval. Continue reading Boehringer's Pink Pill: It Ain't Viagra Boehringer's Pink Pill: It Ain't Viagra originally appeared on DailyFinance on Thu, 17 Jun 2010 20:30:00. Filed Under: Company News , Health Care , Pfizer , Eli Lilly Permalink | Tweet this! | Comments
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here